Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas

Annals of Oncology

Volumn 13, Issue 1, 2002, Pages 161-166

  De Pas, T ^a,f   Curigliano, G ^a   Masci, G ^a   Catania, C ^a   Comandone, A ^b   Boni, C ^c   Tucci, A ^d   Pagani, O ^e   Marrocco, E ^a   De Braud, F ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b GRADENIGO HOSPITAL   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d CARDARELLI HOSPITAL   (Italy)

^e ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^f NONE   (Italy)

Author keywords

Chemotherapy; Continuous infusion; High dose; Ifosfamide; Soft tissue sarcomas

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 0036230963     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf004     Document Type: Article

References (19)

1. Randomized comparison of three adriamycin regimens for treatment of metastatic soft tissue sarcomas
2. Response to ifosfamide and mesna in 124 previously treated patients with metastatic or unresectable sarcoma
3. High dose ifosfamide in the treatment of advanced soft tissue sarcomas
4. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: A phase II study
5. High dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: Is it feasible?
6. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas
7. Comments on: Should patients with advanced soft tissue sarcomas be treated with chemotherapy?
8. Ifosfamide in the elderly: Clinical consideration for a better drug management
9. Efficacy and tolerability of an ifosfamide continuous infusion in soft tissue sarcomas patients
10. Multi-level models for repeated measurement data: Application to quality of life data in clinical trials
11. Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas
12. Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS)
13. Randomised phase III study comparing conventional-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
14. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: A phase II study
15. High dose ifosfamide with mesna uroprotection: A phase I study
16. High dose ifosfamide: Circumvention of resistance to standard dose ifosfamide in advanced soft tissue sarcomas
17. Single agent ifosfamide studies in sarcomas of soft tissue and bone: The MD Anderson experience
18. Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas
19. Increasing 4′-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A pilot study